Aurinia Pharmaceuticals shares owned by UBS Group
Quarter-by-quarter ownership of Aurinia Pharmaceuticals (AUPH) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Aurinia Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Aurinia Pharmaceuticals held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aurinia Pharmaceuticals by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $2.2M | 199k | 11.05 |
| 2025-06-30 | $2.8M | 326k | 8.47 |
| 2025-03-31 | $2.1M | 257k | 8.04 |
| 2024-12-31 | $1.9M | 213k | 8.98 |
| 2024-09-30 | $1.1M | 151k | 7.33 |
| 2024-06-30 | $783k | 137k | 5.71 |
| 2024-03-31 | $1.0M | 201k | 5.01 |
| 2023-12-31 | $2.3M | 254k | 8.99 |
| 2023-09-30 | $1.5M | 192k | 7.75 |
| 2023-06-30 | $2.3M | 242k | 9.68 |
| 2023-03-31 | $1.4M | 132k | 10.96 |
| 2022-12-31 | $201k | 47k | 4.32 |
| 2022-09-30 | $274k | 37k | 7.46 |
| 2022-06-30 | $1.5M | 150k | 10.05 |
| 2022-03-31 | $2.5M | 205k | 12.35 |
| 2021-12-31 | $2.6M | 114k | 22.87 |
| 2021-09-30 | $5.8M | 263k | 22.13 |
| 2021-06-30 | $3.4M | 260k | 12.95 |
| 2021-03-31 | $3.3M | 255k | 12.99 |
| 2020-12-31 | $3.0M | 216k | 13.83 |
| 2020-09-30 | $2.5M | 169k | 14.73 |
| 2020-06-30 | $1.7M | 102k | 16.25 |
| 2020-03-31 | $1.8M | 122k | 14.51 |
| 2019-12-31 | $1.7M | 83k | 20.26 |
| 2019-09-30 | $38k | 7.1k | 5.34 |
| 2019-06-30 | $42k | 6.4k | 6.52 |
| 2019-03-31 | $46k | 7.0k | 6.55 |
| 2018-12-31 | $53k | 8.2k | 6.44 |
| 2018-09-30 | $862k | 129k | 6.68 |
| 2018-06-30 | $678k | 120k | 5.63 |
| 2018-03-31 | $599k | 115k | 5.19 |
| 2017-12-31 | $538k | 119k | 4.53 |
| 2017-09-30 | $582k | 93k | 6.27 |
| 2017-06-30 | $604k | 99k | 6.13 |
| 2017-03-31 | $824k | 112k | 7.34 |
| 2016-12-31 | $208k | 99k | 2.10 |
| 2016-09-30 | $209k | 69k | 3.01 |
| 2016-03-31 | $6.0k | 2.0k | 2.97 |
| 2015-12-31 | $42k | 17k | 2.48 |